Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
3 Pharmaceutical Stocks For Your November 2022 Watchlist
01:00pm, Tuesday, 15'th Nov 2022
3 pharmaceutical stocks to watch in the stock market right now.
Up 15% In A Month Will Bristol Myers Squibb Stock Continue To See Higher Levels?
07:00am, Monday, 14'th Nov 2022
Bristol Myers Squibb stock (NYSE: BMY) is up 15% in a month, slightly outperforming the broader S&P500 index, up 11%.
Is This Blue-Chip Dividend Stock a Buy?
10:23am, Friday, 11'th Nov 2022
Shares of this pharmaceutical stock have surged higher in 2022.
2 Ultra-Safe Passive Income Stocks to Buy Right Now
08:15am, Thursday, 10'th Nov 2022
These two top biopharma stocks are crushing the 2022 bear market.
Biopharma Bristol-Myers Unfazed By Generic Competition For Cancer Cash Cow
03:55pm, Wednesday, 09'th Nov 2022
Biopharma leader Bristol-Myers Squibb posted solid Q3 results, despite competition from generic-drug makers for its popular cancer pill. The post Biopharma Bristol-Myers Unfazed By Generic Competition
Final Trades: PayPal, Merck, Bristol Myers & more
02:29pm, Wednesday, 09'th Nov 2022
The "Halftime Report" traders give their top picks to watch for the second half.
Investing $1,000 in the Current Market? Don't Overlook These 2 Winning Dividend Stocks
07:45am, Tuesday, 08'th Nov 2022
Just because the stock market is going haywire doesn't mean you have to sit on the sidelines.
Final Trades: MCD, SBUX, BMY & NKE
06:09pm, Friday, 28'th Oct 2022
The final trades of the week. With CNBC's Sara Eison and the Fast Money traders, Tim Seymour, Guy Adami, Steve Grasso and Courtney Garcia.
Is Bristol Myers Squibb Stock a Buy With Its New-Product Sales Soaring?
05:52am, Thursday, 27'th Oct 2022
The biopharma company has a lot riding on its new drugs.
Strong Fundamentals Make Bristol Myers Squibb Stock a Real Value
03:01am, Thursday, 27'th Oct 2022
Bristol Myers Squibb stock posts results that establish it as an attractive value stock, even if it may not be as undervalued as it appeared before.
Bristol-Myers Squibb Co (BMY) Q3 2022 Earnings Call Transcript
01:02pm, Wednesday, 26'th Oct 2022
Bristol-Myers Squibb Co (NYSE:BMY ) Q3 2022 Earnings Conference Call October 26, 2022 8:00 AM ET Company Participants Timothy Power - VP & Head, IR Giovanni Caforio - Chairman & CEO David Elkins - EVP
Bristol Myers Squibb CEO: We are on track to continue delivering growth
10:58am, Wednesday, 26'th Oct 2022
Bristol Myers Squibb CEO Dr. Giovanni Caforio joins CNBC's 'Squawk on the Street' to discuss the company's third-quarter earnings report.
Bristol Myers Squibb's stock is up, says Revlimid sales are declining
08:16am, Wednesday, 26'th Oct 2022
Shares of Bristol Myers Squibb BMY, -0.30% were up 1.2% in premarket trading on Wednesday, the day after the company shared better-than-expected results for the third quarter of the year. Bristol had
Bristol Myers Sales Fall on Strong Dollar. But Earnings Beat Expectations.
05:01am, Wednesday, 26'th Oct 2022
Sales of the company's blockbuster cancer drug Revlimid, which has faced increased competition this year, tumbled 28% in the quarter.
Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue Estimates
10:34pm, Tuesday, 25'th Oct 2022
Bristol Myers (BMY) delivered earnings and revenue surprises of 8.74% and 1.63%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
